Bruno Bulic

1.4k total citations
21 papers, 1.2k citations indexed

About

Bruno Bulic is a scholar working on Physiology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Bruno Bulic has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 11 papers in Pharmacology and 7 papers in Computational Theory and Mathematics. Recurrent topics in Bruno Bulic's work include Alzheimer's disease research and treatments (15 papers), Cholinesterase and Neurodegenerative Diseases (10 papers) and Computational Drug Discovery Methods (7 papers). Bruno Bulic is often cited by papers focused on Alzheimer's disease research and treatments (15 papers), Cholinesterase and Neurodegenerative Diseases (10 papers) and Computational Drug Discovery Methods (7 papers). Bruno Bulic collaborates with scholars based in Germany, Switzerland and France. Bruno Bulic's co-authors include Marcus Pickhardt, Eckhard Mandelkow�, Eva‐Maria Mandelkow, Herbert Waldmann, Boris Schmidt, Sascha Weggen, Inna Khlistunova, Jacek Biernat, Suman Jha and Rajesh Mishra and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Bruno Bulic

21 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Bulic Germany 15 813 437 349 253 187 21 1.2k
Kolla Rajasekhar India 18 758 0.9× 528 1.2× 380 1.1× 265 1.0× 93 0.5× 25 1.3k
Christine Mavros Australia 6 1.1k 1.3× 540 1.2× 323 0.9× 196 0.8× 173 0.9× 6 1.7k
Inna Khlistunova Germany 10 980 1.2× 478 1.1× 388 1.1× 236 0.9× 349 1.9× 12 1.3k
Varghese John United States 23 651 0.8× 706 1.6× 407 1.2× 338 1.3× 169 0.9× 66 1.6k
Rashmi Kumar United States 7 916 1.1× 660 1.5× 214 0.6× 247 1.0× 88 0.5× 10 1.2k
Darryl Carrington Australia 5 1.0k 1.3× 366 0.8× 340 1.0× 248 1.0× 107 0.6× 7 1.4k
Fedá E. Ali Australia 12 1.1k 1.3× 512 1.2× 223 0.6× 172 0.7× 175 0.9× 15 1.5k
Keyla Perez Australia 21 1.5k 1.8× 789 1.8× 319 0.9× 304 1.2× 210 1.1× 40 2.1k
Michael R. Nichols United States 21 764 0.9× 567 1.3× 150 0.4× 144 0.6× 85 0.5× 45 1.3k
Alaina S. DeToma United States 13 779 1.0× 345 0.8× 320 0.9× 292 1.2× 65 0.3× 16 1.2k

Countries citing papers authored by Bruno Bulic

Since Specialization
Citations

This map shows the geographic impact of Bruno Bulic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Bulic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Bulic more than expected).

Fields of papers citing papers by Bruno Bulic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Bulic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Bulic. The network helps show where Bruno Bulic may publish in the future.

Co-authorship network of co-authors of Bruno Bulic

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Bulic. A scholar is included among the top collaborators of Bruno Bulic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Bulic. Bruno Bulic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krauthausen, Marius, Markus P. Kummer, Julian Zimmermann, et al.. (2014). CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer’s disease model. Journal of Clinical Investigation. 125(1). 365–378. 104 indexed citations
2.
Bulic, Bruno, Marcus Pickhardt, & Eckhard Mandelkow�. (2013). Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease. Journal of Medicinal Chemistry. 56(11). 4135–4155. 92 indexed citations
3.
Jumpertz, Thorsten, Andreas Rennhack, Sandra Baches, et al.. (2012). Presenilin Is the Molecular Target of Acidic γ-Secretase Modulators in Living Cells. PLoS ONE. 7(1). e30484–e30484. 36 indexed citations
4.
Rennhack, Andreas, Thorsten Jumpertz, Sandra Baches, et al.. (2012). Synthesis of a potent photoreactive acidic γ-secretase modulator for target identification in cells. Bioorganic & Medicinal Chemistry. 20(21). 6523–6532. 10 indexed citations
5.
Zettl, Heiko, Volker Hähnke, Dirk Beher, et al.. (2012). Discovery of γ-Secretase Modulators with a Novel Activity Profile by Text-Based Virtual Screening. ACS Chemical Biology. 7(9). 1488–1495. 4 indexed citations
6.
Heneka, Michael T., Markus P. Kummer, Sascha Weggen, et al.. (2011). Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease. Current Alzheimer Research. 8(2). 115–131. 40 indexed citations
7.
Bulic, Bruno, et al.. (2011). Chemical Biology, Molecular Mechanism and Clinical Perspective of γ - Secretase Modulators in Alzheimers Disease. Current Neuropharmacology. 9(4). 598–622. 35 indexed citations
8.
Heneka, Michael T., Markus P. Kummer, Sascha Weggen, et al.. (2011). Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimer's Disease. Current Alzheimer Research. 999(999). 1–17. 4 indexed citations
9.
Hahn, Stefanie, Stephan Schilling, Torsten Hoffmann, et al.. (2011). No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease. Neurobiology of Aging. 33(4). 833.e39–833.e50. 38 indexed citations
10.
Munter, Lisa Marie, Peter W. Hildebrand, Muralidhar Dasari, et al.. (2010). Amyloid beta 42 peptide (Aβ42)-lowering compounds directly bind to Aβ and interfere with amyloid precursor protein (APP) transmembrane dimerization. Proceedings of the National Academy of Sciences. 107(33). 14597–14602. 91 indexed citations
11.
12.
Bulic, Bruno, Marcus Pickhardt, Eva‐Maria Mandelkow, & Eckhard Mandelkow�. (2010). Tau protein and tau aggregation inhibitors. Neuropharmacology. 59(4-5). 276–289. 152 indexed citations
13.
Bulic, Bruno, Marcus Pickhardt, Boris Schmidt, et al.. (2009). Development of Tau Aggregation Inhibitors for Alzheimer's Disease. Angewandte Chemie International Edition. 48(10). 1740–1752. 236 indexed citations
14.
Bulic, Bruno, Marcus Pickhardt, Boris Schmidt, et al.. (2009). ChemInform Abstract: Development of Tau Aggregation Inhibitors for Alzheimer′s Disease.. ChemInform. 40(20). 3 indexed citations
15.
Bulic, Bruno, Marcus Pickhardt, Boris Schmidt, et al.. (2009). Entwicklung von Inhibitoren der Tau‐Aggregation bei Morbus Alzheimer. Angewandte Chemie. 121(10). 1772–1785. 22 indexed citations
16.
Mishra, Rajesh, Bruno Bulic, Daniel Sellin, et al.. (2008). Small‐Molecule Inhibitors of Islet Amyloid Polypeptide Fibril Formation. Angewandte Chemie International Edition. 47(25). 4679–4682. 100 indexed citations
17.
Bulic, Bruno, Marcus Pickhardt, Inna Khlistunova, et al.. (2007). Rhodanine‐Based Tau Aggregation Inhibitors in Cell Models of Tauopathy. Angewandte Chemie International Edition. 46(48). 9215–9219. 139 indexed citations
18.
Bulic, Bruno, Marcus Pickhardt, Inna Khlistunova, et al.. (2007). Rhodanine‐Based Tau Aggregation Inhibitors in Cell Models of Tauopathy. Angewandte Chemie. 119(48). 9375–9379. 21 indexed citations
19.
Pfaltz, Andreas, Bruno Bulic, & Ulrich Lücking. (2006). Enantioselective Routes to (-)-(R)-Muscone. Synlett. 2006(7). 1031–1034. 2 indexed citations
20.
Michelet, Véronique, Bruno Bulic, Jean‐Pierre Genêt, et al.. (1999). A New Synthetic Approach Toward (+)-Ambruticin Analogs: Preparation of a C10–C11cis-Isomer Fragment. European Journal of Organic Chemistry. 1999(11). 2885–2892. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kolla Rajasekhar Breakdown of academic impact, for papers by Christine Mavros Breakdown of academic impact, for papers by Inna Khlistunova Breakdown of academic impact, for papers by Varghese John Breakdown of academic impact, for papers by Rashmi Kumar Breakdown of academic impact, for papers by Darryl Carrington Breakdown of academic impact, for papers by Fedá E. Ali Breakdown of academic impact, for papers by Keyla Perez Breakdown of academic impact, for papers by Michael R. Nichols Breakdown of academic impact, for papers by Alaina S. DeToma
Rankless by CCL
2026